Status:
COMPLETED
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
20-84 years
Phase:
PHASE3
Brief Summary
The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total knee arthropla...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral total knee arthroplasty
Exclusion
- Subjects with risks of hemorrhage
- Subjects with thromboembolic risks
- Subjects who weigh less than 40 kg
- Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
716 Patients enrolled
Trial Details
Trial ID
NCT01181102
Start Date
March 1 2009
End Date
February 1 2010
Last Update
March 5 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan
2
Tokyo, Japan
3
Kaohsiung City, Taiwan